APA (7th ed.) Citation

E, C., C, P., A, S., M, V., G, D. W., R, S., . . . P, M. (2019). Efficacy and safety of bromfenac 0.09% and sodium hyaluronate 0.4% combination therapy, versus placebo in patients with pterygium I–III for clinical signs on ocular inflammation. Dove Medical Press.

Chicago Style (17th ed.) Citation

E, Chávez-Mondragón, Palacio C, Soto-Gómez A, Villanueva-Nájera M, De Wit-Carter G, Suárez-Velasco R, Baiza-Duran L, Olvera-Montaño O, and Muñoz-Villegas P. Efficacy and Safety of Bromfenac 0.09% and Sodium Hyaluronate 0.4% Combination Therapy, Versus Placebo in Patients with Pterygium I–III for Clinical Signs on Ocular Inflammation. Dove Medical Press, 2019.

MLA (8th ed.) Citation

E, Chávez-Mondragón, et al. Efficacy and Safety of Bromfenac 0.09% and Sodium Hyaluronate 0.4% Combination Therapy, Versus Placebo in Patients with Pterygium I–III for Clinical Signs on Ocular Inflammation. Dove Medical Press, 2019.